跳至主要内容
临床试验/IRCT20201220049774N4
IRCT20201220049774N4尚未招募3 期

Evaluation of the effect of curcumin-piperine supplement administration on the severity of injury and function in patients with acute ischemic stroke

Mashhad University of Medical Sciences0 个研究点目标入组 68 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 80 years(—)
性别
All

入选标准

  • Age between 18 and 80 years
  • Less than 24 hours have passed since the onset of stroke.
  • The patient has been diagnosed with an acute ischemic stroke.
  • GCS of the patient at the time of visit should be more than 13.
  • The NIHSS range is between 5 and 20.
  • MRS is less than 2 before the onset of stroke.
  • Sign the informed consent form

排除标准

  • Patients receiving rtPA
  • Candidate patients for endovascular treatment, mechanical thrombectomy or craniotomy
  • Pregnancy or breastfeeding
  • History of allergy to turmeric or black pepper
  • Taking immunosuppressive drugs
  • Concomitant receipt of any drug or supplement with an antioxidant or anti-inflammatory effect or an approved immune system regulator

研究者

相似试验